IO Biotech Company Insiders

IO Biotech Management Team Effectiveness

The company has return on total asset (ROA) of (0.8858) % which means that it has lost $0.8858 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.4048) %, meaning that it created substantial loss on money invested by shareholders. IO Biotech's management efficiency ratios could be used to measure how well IO Biotech manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.48 in 2025. Return On Capital Employed is likely to gain to -1.88 in 2025. At this time, IO Biotech's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 2.7 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 12.8 M in 2025. Common Stock Shares Outstanding is likely to gain to about 69.2 M in 2025, whereas Net Loss is likely to drop (67.5 M) in 2025.

IO Biotech Workforce Comparison

IO Biotech Insider Trading

IO Biotech Notable Stakeholders

The success or failure of an entity such as IO Biotech often depends on how effective the management is. IO Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of IOBT management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the IOBT management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in IO Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of IO Biotech. Check IO Biotech's Beneish M Score to see the likelihood of IO Biotech's management manipulating its earnings.

When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.